State of New Jersey Common Pension Fund D
ELVN icon

State of New Jersey Common Pension Fund D’s Enliven Therapeutics ELVN Stock Holding History

State of New Jersey Common Pension Fund D’s Portfolio ELVN Stock Details ELVN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$550K Sell
10,829
-326
-3% -$13.8K ﹤0.01% 1624
2026
Q1 		$437K Buy
+11,155
New +$309K ﹤0.01% 1470

Other funds holding ELVN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
TCM
TimesSquare Capital Management New York $6.8B AUM 45.85% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

State of New Jersey Common Pension Fund D's ELVN Position: Q2 2026 in Review

State of New Jersey Common Pension Fund D reduced its Enliven Therapeutics (ELVN) stake by 2.9% in Q2 2026, selling an estimated $13.8K and leaving 10,829 shares worth $550K. The position accounts for ﹤0.01% of the portfolio, ranked #1624.

State of New Jersey Common Pension Fund D first reported a position in ELVN in Q1 2026 and has held it in 2 quarters since. 49 funds tracked by Wall St. Rank hold ELVN as of Q2 2026.

  • State of New Jersey Common Pension Fund D held 10,829 shares of Enliven Therapeutics worth $550K as of Q2 2026.
  • State of New Jersey Common Pension Fund D sold 326 Enliven Therapeutics shares in Q2 2026, an estimated $13.8K.
  • Enliven Therapeutics made up ﹤0.01% of State of New Jersey Common Pension Fund D's portfolio in Q2 2026, its #1624 holding.
  • State of New Jersey Common Pension Fund D first reported a position in Enliven Therapeutics in Q1 2026 and has held it in 2 quarters since.
  • 49 funds tracked by Wall St. Rank held Enliven Therapeutics as of Q2 2026.

Based on State of New Jersey Common Pension Fund D's 13F filing for Q2 2026, filed 4 Aug 2026.